UPDATE : Monday, September 7, 2020
상단여백
MSD Korea, Mundipharma Korea in mandatory work-from-home mode, again by Kim Yun-mi 2020-05-12 11:57
SGLT-2 inhibitor’s renal function benefit recognized limitedly by Kim Yun-mi 2020-05-11 14:48
‘Roche’s Kadcyla allows early breast cancer patients to continue social life’ by Kim Yun-mi 2020-05-08 15:51
‘Government should stock Covid-19 vaccines even after virus disappears’ by Kim Yun-mi 2020-05-07 16:43
US expert notices Korea’s response to Covid-19 outbreak at call center by Kim Yun-mi 2020-05-06 15:48
라인
New law takes effect to spur growth of in vitro diagnostic devices by Kim Yun-mi 2020-05-01 15:35
‘Keytruda alone works as first-line therapy for lung cancer’ by Kim Yun-mi 2020-04-29 11:40
Researchers start testing pancreatitis drug to fight Covid-19 by Kim Yun-mi 2020-04-28 11:22
Multinational drugmakers donated ₩30 billion last year by Kim Yun-mi 2020-04-23 15:09
Samsung app wins nod for checking blood pressure on smartwatch by Kim Yun-mi 2020-04-21 16:59
라인
Researchers to test asthma drug to treat Covid-19 by Kim Yun-mi 2020-04-16 16:20
Opdivo’s indication expanded to esophageal squamous cell carcinoma by Kim Yun-mi 2020-04-16 10:48
Gilead revised clinical design of potential COVID-19 drug remdesivir. Why? by Kim Yun-mi 2020-04-10 15:36
Review of cancer drug benefits delayed amid social distancing by Kim Yun-mi 2020-04-08 13:46
‘Computerized insulin infusion controls glucose faster, safer’ by Kim Yun-mi 2020-04-07 18:38
라인
Pfizer, MSD put off reorganizing due to COVID-19 by Kim Yun-mi 2020-04-03 17:09
‘Early aspirin cut reduced bleeding in acute coronary syndrome patients’ by Kim Yun-mi 2020-04-02 15:08
Korea could lead global standard for infectious disease diagnosis by Kim Yun-mi 2020-03-30 16:03
[Feature] Medical societies shift to online conferences in light of COVID-19 by Kim Yun-mi 2020-03-30 14:30
2 drugmakers react differently to coronavirus pandemic by Kim Yun-mi 2020-03-26 13:36
여백
여백
여백
Back to Top